- About Us
- Nano-Social Network
- Nano Consulting
- My Account
October 17th, 2007
Tampa's TransGenex names Lucas CEO, president
TransGenex Nanobiotech Inc. has named John E. Lucas CEO and president.
Formerly chairman and CEO of EpiCept Corp., Lucas has also had experience with startups.
TransGenex is developing novel nanoparticle platform technologies to diagnose and treat a number of diseases. The company licensed its patents from the University of South Florida.
|Related News Press|
In-cell molecular sieve from protein crystal February 14th, 2017
Cedars-Sinai, UCLA Scientists Use New ‘Blood Biopsies’ With Experimental Device to Speed Cancer Diagnosis and Predict Disease Spread: Leading-Edge Research Is Part of National Cancer Moonshot Initiative February 13th, 2017
Tiny nanoclusters could solve big problems for lithium-ion batteries February 21st, 2017
Breakthrough with a chain of gold atoms: In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport February 20th, 2017
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016